Nearly 3,700 substitute teachers needed in NYC ahead of vaccine deadline – New York Post
TrustVaccines
via vaccines https://ift.tt/2RLxrYd
October 3, 2021 at 07:19PM
Latest News
BioNTech chief predicts need for updated Covid vaccines next year – Financial Times
BioNTech chief predicts need for updated Covid vaccines next year – Financial Times
TrustVaccines
via vaccines https://ift.tt/2RLxrYd
October 3, 2021 at 06:40AM
Biden sued by Air Force officers who compare vaccine rule to death sentence – Ars Technica
Biden sued by Air Force officers who compare vaccine rule to death sentence – Ars Technica
TrustVaccines
via vaccines https://ift.tt/2RLxrYd
October 2, 2021 at 03:35PM
Getting Flu Shot and Covid Vaccine Is Not Dangerous, Study Finds – The New York Times
Getting Flu Shot and Covid Vaccine Is Not Dangerous, Study Finds – The New York Times
TrustVaccines
via vaccines https://ift.tt/2RLxrYd
October 1, 2021 at 02:43AM
NYC vaccine mandate takes effect with 96% of teachers receiving at least one dose, mayor says – CNN
NYC vaccine mandate takes effect with 96% of teachers receiving at least one dose, mayor says – CNN
TrustVaccines
via vaccines https://ift.tt/2RLxrYd
October 4, 2021 at 01:13PM
Wyoming Vaccine Mandate Could Stretch Hospital Staffing, Officials Say – The New York Times
Wyoming Vaccine Mandate Could Stretch Hospital Staffing, Officials Say – The New York Times
TrustVaccines
via vaccines https://ift.tt/2RLxrYd
September 30, 2021 at 12:37PM
Anti-vaxxers trying to disrupt Australian rollout by making fake vaccine bookings – The Guardian Australia
Anti-vaxxers trying to disrupt Australian rollout by making fake vaccine bookings – The Guardian Australia
TrustVaccines
via vaccines https://ift.tt/2RLxrYd
October 4, 2021 at 08:34PM
Sen. Lindsey Graham booed by South Carolina Republicans after promoting covid vaccine – The Washington Post
Sen. Lindsey Graham booed by South Carolina Republicans after promoting covid vaccine – The Washington Post
TrustVaccines
via vaccines https://ift.tt/2RLxrYd
October 5, 2021 at 08:00AM
Merck’s molnupiravir will be ‘complementary, but not a competitor’ to COVID-19 vaccines: analyst
Merck’s molnupiravir will be ‘complementary, but not a competitor’ to COVID-19 vaccines: analyst
TrustVaccines
via FiercePharma: Vaccines https://ift.tt/2zKtXvv
October 5, 2021 at 09:39AM
Cancer patients on chemotherapy likely not fully protected by COVID-19 vaccine, study finds
Cancer patients on chemotherapy likely not fully protected by COVID-19 vaccine, study finds
TrustVaccines
via Vaccines News — ScienceDaily https://ift.tt/2FDCILY
October 5, 2021 at 08:21AM
Welcome to vaccine education 